{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:58:00Z","timestamp":1791903480747,"version":"4.3.4"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Department of Anatomical pathology"},{"name":"Tohoku University School of Graduate Medicine"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.mce.2018.10.019","type":"journal-article","created":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T12:15:24Z","timestamp":1541420124000},"page":"32-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["The role of 17\u03b2HSDs in breast tissue and breast cancers"],"prefix":"10.1016","volume":"489","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1982-5737","authenticated-orcid":false,"given":"Keely May","family":"McNamara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Sasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mce.2018.10.019_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10549-011-1536-9","article-title":"Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles","volume":"132","author":"Agyeman","year":"2012","journal-title":"Breast Canc. Res. Treat."},{"key":"10.1016\/j.mce.2018.10.019_bib2","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.dib.2016.11.010","article-title":"Genomic data on breast cancer transcript profile modulation by 17beta-hydroxysteroid dehydrogenase type 1 and 17-beta-estradiol","volume":"9","author":"Aka","year":"2016","journal-title":"Data Brief"},{"key":"10.1016\/j.mce.2018.10.019_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.mce.2016.08.026","article-title":"Estradiol-independent modulation of breast cancer transcript profile by 17beta-hydroxysteroid dehydrogenase type 1","volume":"439","author":"Aka","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"issue":"4","key":"10.1016\/j.mce.2018.10.019_bib4","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1210\/me.2009-0468","article-title":"17beta-hydroxysteroid dehydrogenase type 1 stimulates breast cancer by dihydrotestosterone inactivation in addition to estradiol production","volume":"24","author":"Aka","year":"2010","journal-title":"Mol. Endocrinol."},{"issue":"3","key":"10.1016\/j.mce.2018.10.019_bib5","doi-asserted-by":"crossref","first-page":"R92","DOI":"10.1186\/bcr3207","article-title":"17beta-hydroxysteroid dehydrogenase type 1 modulates breast cancer protein profile and impacts cell migration","volume":"14","author":"Aka","year":"2012","journal-title":"Breast Cancer Res."},{"issue":"1\u20132","key":"10.1016\/j.mce.2018.10.019_bib6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.mce.2006.04.029","article-title":"Paracrine-stimulated gene expression profile favors estradiol production in breast tumors","volume":"253","author":"Amin","year":"2006","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1","key":"10.1016\/j.mce.2018.10.019_bib7","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/s41467-017-01027-z","article-title":"Comprehensive analysis of normal adjacent to tumor transcriptomes","volume":"8","author":"Aran","year":"2017","journal-title":"Nat. Commun."},{"issue":"2B","key":"10.1016\/j.mce.2018.10.019_bib8","first-page":"1101","article-title":"17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast","volume":"20","author":"Ariga","year":"2000","journal-title":"Anticancer Res."},{"issue":"3","key":"10.1016\/j.mce.2018.10.019_bib9","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10549-014-2990-y","article-title":"Expression of membrane transporters and metabolic enzymes involved in estrone-3-sulphate disposition in human breast tumour tissues","volume":"145","author":"Banerjee","year":"2014","journal-title":"Breast Canc. Res. Treat."},{"issue":"2","key":"10.1016\/j.mce.2018.10.019_bib10","doi-asserted-by":"crossref","first-page":"E360","DOI":"10.1210\/jc.2010-0912","article-title":"Comprehensive analysis of hormone and genetic variation in 36 genes related to steroid hormone metabolism in pre- and postmenopausal women from the breast and prostate cancer cohort consortium (BPC3)","volume":"96","author":"Beckmann","year":"2011","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"1\u20132","key":"10.1016\/j.mce.2018.10.019_bib11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0303-7207(00)00416-0","article-title":"17beta-hydroxysteroid dehydrogenase type 7--an ancient 3-ketosteroid reductase of cholesterogenesis","volume":"171","author":"Breitling","year":"2001","journal-title":"Mol. Cell. Endocrinol."},{"issue":"3","key":"10.1016\/j.mce.2018.10.019_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jsbmb.2009.12.009","article-title":"Aldo-keto reductase 1C3 expression in MCF-7 cells reveals roles in steroid hormone and prostaglandin metabolism that may explain its over-expression in breast cancer","volume":"118","author":"Byrns","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1\u20133","key":"10.1016\/j.mce.2018.10.019_bib13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.cbi.2008.10.024","article-title":"Type 5 17beta-hydroxysteroid dehydrogenase\/prostaglandin F synthase (AKR1C3): role in breast cancer and inhibition by non-steroidal anti-inflammatory drug analogs","volume":"178","author":"Byrns","year":"2009","journal-title":"Chem. Biol. Interact."},{"issue":"3","key":"10.1016\/j.mce.2018.10.019_bib14","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10549-010-0785-3","article-title":"Increased estrogen sulfatase (STS) and 17beta-hydroxysteroid dehydrogenase type 1(17beta-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients","volume":"120","author":"Chanplakorn","year":"2010","journal-title":"Breast Canc. Res. Treat."},{"issue":"1","key":"10.1016\/j.mce.2018.10.019_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12672-010-0062-2","article-title":"Increased 5alpha-reductase type 2 expression in human breast carcinoma following aromatase inhibitor therapy: the correlation with decreased tumor cell proliferation","volume":"2","author":"Chanplakorn","year":"2011","journal-title":"Horm Cancer"},{"issue":"2","key":"10.1016\/j.mce.2018.10.019_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172244","article-title":"Alterations in estrogen signalling pathways upon acquisition of anthracycline resistance in breast tumor cells","volume":"12","author":"Chewchuk","year":"2017","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.mce.2018.10.019_bib17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12672-017-0314-5","article-title":"Harnessing a different dependency: how to identify and target androgen receptor-positive versus quadruple-negative breast cancer","volume":"9","author":"Christenson","year":"2018","journal-title":"Horm Cancer"},{"issue":"9","key":"10.1016\/j.mce.2018.10.019_bib18","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/ijc.23350","article-title":"17beta-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer","volume":"122","author":"Day","year":"2008","journal-title":"Int. J. Canc."},{"issue":"1\u20132","key":"10.1016\/j.mce.2018.10.019_bib19","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.mce.2006.01.011","article-title":"17Beta-hydroxysteroid dehydrogenase Type 1 and Type 2: association between mRNA expression and activity in cell lines","volume":"248","author":"Day","year":"2006","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1","key":"10.1016\/j.mce.2018.10.019_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10549-009-0363-8","article-title":"Expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression","volume":"120","author":"Fu","year":"2010","journal-title":"Breast Canc. Res. Treat."},{"issue":"12","key":"10.1016\/j.mce.2018.10.019_bib21","doi-asserted-by":"crossref","first-page":"19039","DOI":"10.18632\/oncotarget.15118","article-title":"Pathological complete response of HER2-positive breast cancer to trastuzumab and chemotherapy can be predicted by HSD17B4 methylation","volume":"8","author":"Fujii","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.mce.2018.10.019_bib22","first-page":"113","article-title":"The 17beta-hydroxysteroid dehydrogenase type 3 deficiency: a case report of an 18-year patient and review of the literature","volume":"38","author":"Galdiero","year":"2013","journal-title":"Minerva Endocrinol."},{"key":"10.1016\/j.mce.2018.10.019_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mce.2017.09.014","article-title":"Obesity and breast cancer - role of estrogens and the molecular underpinnings of aromatase regulation in breast adipose tissue","volume":"466","author":"Gerard","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"issue":"3","key":"10.1016\/j.mce.2018.10.019_bib24","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.bjc.6602375","article-title":"17beta-Hydroxysteroid dehydrogenases involved in local oestrogen synthesis have prognostic significance in breast cancer","volume":"92","author":"Gunnarsson","year":"2005","journal-title":"Br. J. Canc."},{"issue":"2","key":"10.1016\/j.mce.2018.10.019_bib25","first-page":"219","article-title":"Expression of COX-2 and steroid converting enzymes in breast cancer","volume":"16","author":"Gunnarsson","year":"2006","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.mce.2018.10.019_bib26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10549-007-9579-7","article-title":"Amplification of HSD17B1 has prognostic significance in postmenopausal breast cancer","volume":"108","author":"Gunnarsson","year":"2008","journal-title":"Breast Canc. Res. Treat."},{"issue":"23","key":"10.1016\/j.mce.2018.10.019_bib27","first-page":"8448","article-title":"Abnormal expression of 17beta-hydroxysteroid dehydrogenases in breast cancer predicts late recurrence","volume":"61","author":"Gunnarsson","year":"2001","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.mce.2018.10.019_bib28","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1210\/me.2004-0479","article-title":"Steroids and the scientist","volume":"19","author":"Gustafsson","year":"2005","journal-title":"Mol. Endocrinol."},{"issue":"4\u20135","key":"10.1016\/j.mce.2018.10.019_bib29","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jsbmb.2008.10.004","article-title":"Expression of 17beta-hydroxysteroid dehydrogenase type 2 and type 5 in breast cancer and adjacent non-malignant tissue: a correlation to clinicopathological parameters","volume":"112","author":"Han","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2018.10.019_bib30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jsbmb.2017.05.011","article-title":"Substrate inhibition of 17beta-HSD1 in living cells and regulation of 17beta-HSD7 by 17beta-HSD1 knockdown","volume":"172","author":"Han","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"6","key":"10.1016\/j.mce.2018.10.019_bib31","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1158\/1078-0432.CCR-09-2481","article-title":"Intratumoral estrogen disposition in breast cancer","volume":"16","author":"Haynes","year":"2010","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.mce.2018.10.019_bib32","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/1471-2407-12-381","article-title":"Role of aldo-keto reductases and other doxorubicin pharmacokinetic genes in doxorubicin resistance, DNA binding, and subcellular localization","volume":"12","author":"Heibein","year":"2012","journal-title":"BMC Canc."},{"issue":"2","key":"10.1016\/j.mce.2018.10.019_bib33","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s10549-011-1772-z","article-title":"Polymorphism Thr160Thr in SRD5A1, involved in the progesterone metabolism, modifies postmenopausal breast cancer risk associated with menopausal hormone therapy","volume":"131","author":"Hein","year":"2012","journal-title":"Breast Canc. Res. Treat."},{"issue":"3","key":"10.1016\/j.mce.2018.10.019_bib34","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bcp.2015.05.005","article-title":"Pharmacokinetic interactions of breast cancer chemotherapeutics with human doxorubicin reductases","volume":"96","author":"Hofman","year":"2015","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.mce.2018.10.019_bib35","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1210\/jc.2005-1967","article-title":"Estrogen-metabolizing enzymes in breast cancers from women over the age of 80 years","volume":"91","author":"Honma","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.mce.2018.10.019_bib36","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/1097-0142(19910215)67:4<886::AID-CNCR2820670405>3.0.CO;2-O","article-title":"Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis","volume":"67","author":"Ingle","year":"1991","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.mce.2018.10.019_bib37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.canlet.2005.11.010","article-title":"Quantitative analysis of aromatase, sulfatase and 17beta-HSD(1) mRNA expression in soft tissue metastases of breast cancer","volume":"243","author":"Irahara","year":"2006","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.mce.2018.10.019_bib38","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10549-006-9477-4","article-title":"A new polymorphism in the coding region of exon four in HSD17B2 in relation to risk of sporadic and hereditary breast cancer","volume":"106","author":"Jansson","year":"2007","journal-title":"Breast Canc. Res. Treat."},{"issue":"10","key":"10.1016\/j.mce.2018.10.019_bib39","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1158\/1078-0432.CCR-08-2599","article-title":"Ratio of 17HSD1 to 17HSD2 protein expression predicts the outcome of tamoxifen treatment in postmenopausal breast cancer patients","volume":"15","author":"Jansson","year":"2009","journal-title":"Clin. Canc. Res."},{"issue":"3","key":"10.1016\/j.mce.2018.10.019_bib40","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1677\/erc.1.01181","article-title":"Proliferative responses to altered 17beta-hydroxysteroid dehydrogenase (17HSD) type 2 expression in human breast cancer cells are dependent on endogenous expression of 17HSD type 1 and the oestradiol receptors","volume":"13","author":"Jansson","year":"2006","journal-title":"Endocr. Relat. Canc."},{"issue":"23","key":"10.1016\/j.mce.2018.10.019_bib41","doi-asserted-by":"crossref","first-page":"11471","DOI":"10.1158\/0008-5472.CAN-06-1448","article-title":"17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer","volume":"66","author":"Jansson","year":"2006","journal-title":"Cancer Res."},{"issue":"20","key":"10.1016\/j.mce.2018.10.019_bib42","doi-asserted-by":"crossref","first-page":"7610","DOI":"10.1158\/0008-5472.CAN-04-1608","article-title":"Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling","volume":"64","author":"Ji","year":"2004","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.mce.2018.10.019_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097448","article-title":"Modulated expression of genes encoding estrogen metabolizing enzymes by G1-phase cyclin-dependent kinases 6 and 4 in human breast cancer cells","volume":"9","author":"Jia","year":"2014","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.mce.2018.10.019_bib44","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s10549-017-4464-5","article-title":"Effects of cytokines derived from cancer-associated fibroblasts on androgen synthetic enzymes in estrogen receptor-negative breast carcinoma","volume":"166","author":"Kikuchi","year":"2017","journal-title":"Breast Canc. Res. Treat."},{"issue":"1\u20132","key":"10.1016\/j.mce.2018.10.019_bib45","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0303-7207(00)00422-6","article-title":"Phytoestrogens inhibit human 17beta-hydroxysteroid dehydrogenase type 5","volume":"171","author":"Krazeisen","year":"2001","journal-title":"Mol. Cell. Endocrinol."},{"issue":"3\u20135","key":"10.1016\/j.mce.2018.10.019_bib46","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jsbmb.2009.02.006","article-title":"Selective inhibition of 17beta-hydroxysteroid dehydrogenase type 1 (17betaHSD1) reduces estrogen responsive cell growth of T47-D breast cancer cells","volume":"114","author":"Kruchten","year":"2009","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1\u20132","key":"10.1016\/j.mce.2018.10.019_bib47","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.mce.2008.08.026","article-title":"Relative involvement of three 17beta-hydroxysteroid dehydrogenases (types 1, 7 and 12) in the formation of estradiol in various breast cancer cell lines using selective inhibitors","volume":"301","author":"Laplante","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2018.10.019_bib48","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2407-4-27","article-title":"Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma","volume":"4","author":"Lewis","year":"2004","journal-title":"BMC Canc."},{"issue":"3","key":"10.1016\/j.mce.2018.10.019_bib49","first-page":"273","article-title":"Expression of enzymes involved in synthesis and metabolism of estradiol in human breast as studied by immunocytochemistry and in situ hybridization","volume":"24","author":"Li","year":"2009","journal-title":"Histol. Histopathol."},{"issue":"13\u201314","key":"10.1016\/j.mce.2018.10.019_bib50","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.steroids.2004.09.014","article-title":"Characterization of a monoclonal antibody for human aldo-keto reductase AKR1C3 (type 2 3alpha-hydroxysteroid dehydrogenase\/type 5 17beta-hydroxysteroid dehydrogenase); immunohistochemical detection in breast and prostate","volume":"69","author":"Lin","year":"2004","journal-title":"Steroids"},{"issue":"1\u20136","key":"10.1016\/j.mce.2018.10.019_bib51","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0960-0760(99)00062-X","article-title":"3D-structure of human estrogenic 17beta-HSD1: binding with various steroids","volume":"69","author":"Lin","year":"1999","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1\u20132","key":"10.1016\/j.mce.2018.10.019_bib52","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.mce.2005.11.035","article-title":"Structural basis of the multispecificity demonstrated by 17beta-hydroxysteroid dehydrogenase types 1 and 5","volume":"248","author":"Lin","year":"2006","journal-title":"Mol. Cell. Endocrinol."},{"issue":"13","key":"10.1016\/j.mce.2018.10.019_bib53","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1158\/0008-5472.CAN-04-3714","article-title":"Selective insensitivity of ZR-75-1 human breast cancer cells to 2-methoxyestradiol: evidence for type II 17beta-hydroxysteroid dehydrogenase as the underlying cause","volume":"65","author":"Liu","year":"2005","journal-title":"Cancer Res."},{"issue":"1\u20133","key":"10.1016\/j.mce.2018.10.019_bib54","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cbi.2012.09.024","article-title":"Pathophysiological roles of aldo-keto reductases (AKR1C1 and AKR1C3) in development of cisplatin resistance in human colon cancers","volume":"202","author":"Matsunaga","year":"2013","journal-title":"Chem. Biol. Interact."},{"issue":"5","key":"10.1016\/j.mce.2018.10.019_bib55","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/cas.12121","article-title":"Androgenic pathway in triple negative invasive ductal tumours: its correlation with tumour cell proliferation","volume":"104","author":"McNamara","year":"2013","journal-title":"Cancer Sci."},{"issue":"9","key":"10.1016\/j.mce.2018.10.019_bib56","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/s41416-018-0034-9","article-title":"In breast cancer subtypes steroid sulfatase (STS) is associated with less aggressive tumour characteristics","volume":"118","author":"McNamara","year":"2018","journal-title":"Br. J. Canc."},{"issue":"4","key":"10.1016\/j.mce.2018.10.019_bib57","doi-asserted-by":"crossref","first-page":"T161","DOI":"10.1530\/ERC-14-0243","article-title":"Complexities of androgen receptor signalling in breast cancer","volume":"21","author":"McNamara","year":"2014","journal-title":"Endocr. Relat. Canc."},{"issue":"2","key":"10.1016\/j.mce.2018.10.019_bib58","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10549-016-4050-2","article-title":"The presence and impact of estrogen metabolism on the biology of triple-negative breast cancer","volume":"161","author":"McNamara","year":"2017","journal-title":"Breast Canc. Res. Treat."},{"issue":"3","key":"10.1016\/j.mce.2018.10.019_bib59","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/MED.0000000000000251","article-title":"Androgen and breast cancer: an update","volume":"23","author":"McNamara","year":"2016","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"2","key":"10.1016\/j.mce.2018.10.019_bib60","doi-asserted-by":"crossref","first-page":"e184","DOI":"10.5301\/jbm.5000132","article-title":"Androgen receptor and enzymes in lymph node metastasis and cancer reoccurrence in triple-negative breast cancer","volume":"30","author":"McNamara","year":"2015","journal-title":"Int. J. Biol. Markers"},{"issue":"2","key":"10.1016\/j.mce.2018.10.019_bib61","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10549-014-2942-6","article-title":"Androgenic pathways in the progression of triple-negative breast carcinoma: a comparison between aggressive and non-aggressive subtypes","volume":"145","author":"McNamara","year":"2014","journal-title":"Breast Canc. Res. Treat."},{"issue":"2","key":"10.1016\/j.mce.2018.10.019_bib62","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1006217400137","article-title":"17Beta-hydroxysteroid dehydrogenases in normal human mammary epithelial cells and breast tissue","volume":"57","author":"Miettinen","year":"1999","journal-title":"Breast Canc. Res. Treat."},{"issue":"8","key":"10.1016\/j.mce.2018.10.019_bib63","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1158\/0008-5472.CAN-06-3105","article-title":"Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells","volume":"67","author":"Miki","year":"2007","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.mce.2018.10.019_bib64","first-page":"2288","article-title":"High expression of steroid sulfatase mRNA predicts poor prognosis in patients with estrogen receptor-positive breast cancer","volume":"9","author":"Miyoshi","year":"2003","journal-title":"Clin. Canc. Res."},{"issue":"5","key":"10.1016\/j.mce.2018.10.019_bib65","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/ijc.1525","article-title":"Involvement of up-regulation of 17beta-hydroxysteroid dehydrogenase type 1 in maintenance of intratumoral high estradiol levels in postmenopausal breast cancers","volume":"94","author":"Miyoshi","year":"2001","journal-title":"Int. J. Canc."},{"issue":"3","key":"10.1016\/j.mce.2018.10.019_bib66","first-page":"212","article-title":"Steroid hormone synthetic pathways in prostate cancer","volume":"2","author":"Mostaghel","year":"2013","journal-title":"Transl. Androl. Urol."},{"issue":"1\u20132","key":"10.1016\/j.mce.2018.10.019_bib67","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.mce.2009.04.002","article-title":"Transcriptional regulation of 17beta-hydroxysteroid dehydrogenase type 12 by SREBP-1","volume":"307","author":"Nagasaki","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2018.10.019_bib68","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.mce.2017.06.013","article-title":"Development of selective androgen receptor modulators (SARMs)","volume":"465","author":"Narayanan","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1","key":"10.1016\/j.mce.2018.10.019_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2008.06.858","article-title":"Inactivation of the anticancer drugs doxorubicin and oracin by aldo-keto reductase (AKR) 1C3","volume":"181","author":"Novotna","year":"2008","journal-title":"Toxicol. Lett."},{"issue":"2","key":"10.1016\/j.mce.2018.10.019_bib70","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10549-013-2448-7","article-title":"Confirmation of the reduction of hormone replacement therapy-related breast cancer risk for carriers of the HSD17B1_937_G variant","volume":"138","author":"Obazee","year":"2013","journal-title":"Breast Canc. Res. Treat."},{"issue":"20","key":"10.1016\/j.mce.2018.10.019_bib71","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1158\/0008-5472.CAN-04-0446","article-title":"17beta-hydroxysteroid dehydrogenase type 1 is an independent prognostic marker in breast cancer","volume":"64","author":"Oduwole","year":"2004","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.mce.2018.10.019_bib72","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.prp.2009.11.006","article-title":"Gene expression patterns distinguish breast carcinomas from normal breast tissues: the Malaysian context","volume":"206","author":"Pau Ni","year":"2010","journal-title":"Pathol. Res. Pract."},{"issue":"1","key":"10.1016\/j.mce.2018.10.019_bib73","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1677\/jme.0.0260011","article-title":"Immunoelectron microscopic localization of 3beta-hydroxysteroid dehydrogenase and type 5 17beta-hydroxysteroid dehydrogenase in the human prostate and mammary gland","volume":"26","author":"Pelletier","year":"2001","journal-title":"J. Mol. Endocrinol."},{"issue":"6","key":"10.1016\/j.mce.2018.10.019_bib74","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1177\/002215549904700602","article-title":"Immunocytochemical localization of type 5 17beta-hydroxysteroid dehydrogenase in human reproductive tissues","volume":"47","author":"Pelletier","year":"1999","journal-title":"J. Histochem. Cytochem."},{"issue":"3\u20135","key":"10.1016\/j.mce.2018.10.019_bib75","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jsbmb.2009.05.005","article-title":"Analysis of 17beta-hydroxysteroid dehydrogenase types 5, 7, and 12 genetic sequence variants in breast cancer cases from French Canadian Families with high risk of breast and ovarian cancer","volume":"116","author":"Plourde","year":"2009","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"4","key":"10.1016\/j.mce.2018.10.019_bib76","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1677\/JME-07-0101","article-title":"Mutation analysis and characterization of HSD17B2 sequence variants in breast cancer cases from French Canadian families with high risk of breast and ovarian cancer","volume":"40","author":"Plourde","year":"2008","journal-title":"J. Mol. Endocrinol."},{"issue":"3","key":"10.1016\/j.mce.2018.10.019_bib77","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1042\/BJ20111286","article-title":"Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily","volume":"440","author":"Ruiz","year":"2011","journal-title":"Biochem. J."},{"issue":"4\u20135","key":"10.1016\/j.mce.2018.10.019_bib78","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jsbmb.2006.01.010","article-title":"Systemic distribution and tissue localizations of human 17beta-hydroxysteroid dehydrogenase type 12","volume":"99","author":"Sakurai","year":"2006","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"2","key":"10.1016\/j.mce.2018.10.019_bib79","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10549-006-9198-8","article-title":"The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer","volume":"99","author":"Salhab","year":"2006","journal-title":"Breast Canc. Res. Treat."},{"issue":"10","key":"10.1016\/j.mce.2018.10.019_bib80","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1111\/j.1349-7006.2010.01673.x","article-title":"Immunolocalization of estrogen-producing and metabolizing enzymes in benign breast disease: comparison with normal breast and breast carcinoma","volume":"101","author":"Sasaki","year":"2010","journal-title":"Cancer Sci."},{"issue":"12","key":"10.1016\/j.mce.2018.10.019_bib81","doi-asserted-by":"crossref","first-page":"E2661","DOI":"10.1210\/jc.2014-2550","article-title":"Breast adipose tissue estrogen metabolism in postmenopausal women with or without breast cancer","volume":"99","author":"Savolainen-Peltonen","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.mce.2018.10.019_bib82","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1210\/me.2010-0261","article-title":"The stimulation of HSD17B7 expression by estradiol provides a powerful feed-forward mechanism for estradiol biosynthesis in breast cancer cells","volume":"25","author":"Shehu","year":"2011","journal-title":"Mol. Endocrinol."},{"issue":"10","key":"10.1016\/j.mce.2018.10.019_bib83","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.humpath.2013.04.021","article-title":"Androgen and androgen-metabolizing enzymes in metastasized lymph nodes of breast cancer","volume":"44","author":"Shibahara","year":"2013","journal-title":"Hum. Pathol."},{"issue":"1","key":"10.1016\/j.mce.2018.10.019_bib84","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1677\/ERC-07-0092","article-title":"Intratumoral concentration of sex steroids and expression of sex steroid-producing enzymes in ductal carcinoma in situ of human breast","volume":"15","author":"Shibuya","year":"2008","journal-title":"Endocr. Relat. Canc."},{"issue":"7","key":"10.1016\/j.mce.2018.10.019_bib85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040568","article-title":"17beta-Hydroxysteroid dehydrogenase type 14 is a predictive marker for tamoxifen response in oestrogen receptor positive breast cancer","volume":"7","author":"Sivik","year":"2012","journal-title":"PloS One"},{"issue":"1\u20133","key":"10.1016\/j.mce.2018.10.019_bib86","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.cbi.2008.10.015","article-title":"AKR1C3 as a potential target for the inhibitory effect of dietary flavonoids","volume":"178","author":"Skarydova","year":"2009","journal-title":"Chem. Biol. Interact."},{"issue":"4","key":"10.1016\/j.mce.2018.10.019_bib87","first-page":"1190","article-title":"17Beta-hydroxysteroid dehydrogenase type 1 in normal breast tissue during the menstrual cycle and hormonal contraception","volume":"83","author":"Soderqvist","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2\u20133","key":"10.1016\/j.mce.2018.10.019_bib88","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jsbmb.2006.06.015","article-title":"Expression of aromatase and 17beta-hydroxysteroid dehydrogenase types 1, 7 and 12 in breast cancer. An immunocytochemical study","volume":"101","author":"Song","year":"2006","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.mce.2018.10.019_bib89","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0960-0760(98)00119-8","article-title":"Activity and gene expression of 17beta-hydroxysteroid dehydrogenase type I in primary cultures of epithelial and stromal cells derived from normal and tumourous human breast tissue: the role of IL-8","volume":"67","author":"Speirs","year":"1998","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"4","key":"10.1016\/j.mce.2018.10.019_bib90","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/sj.bjc.6690749","article-title":"In vivo and in vitro expression of steroid-converting enzymes in human breast tumours: associations with interleukin-6","volume":"81","author":"Speirs","year":"1999","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.mce.2018.10.019_bib91","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jsbmb.2014.02.003","article-title":"Effects of SNP variants in the 17beta-HSD2 and 17beta-HSD7 genes and 17beta-HSD7 copy number on gene transcript and estradiol levels in breast cancer tissue","volume":"143","author":"Straume","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.mce.2018.10.019_bib92","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3109\/14756366.2014.943205","article-title":"The impact of testosterone, tibolone and black cohosh on purified mammary and placental 17beta-hydroxysteroid dehydrogenase type 1","volume":"30","author":"Stute","year":"2015","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"3\u20135","key":"10.1016\/j.mce.2018.10.019_bib93","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jsbmb.2008.12.008","article-title":"Expression level of enzymes related to in situ estrogen synthesis and clinicopathological parameters in breast cancer patients","volume":"113","author":"Suzuki","year":"2009","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.mce.2018.10.019_bib94","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1054\/bjoc.1999.0956","article-title":"17Beta-hydroxysteroid dehydrogenase type 1 and type 2 in human breast carcinoma: a correlation to clinicopathological parameters","volume":"82","author":"Suzuki","year":"2000","journal-title":"Br. J. Canc."},{"issue":"2","key":"10.1016\/j.mce.2018.10.019_bib95","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1677\/ERC-09-0257","article-title":"Increased intratumoral androgens in human breast carcinoma following aromatase inhibitor exemestane treatment","volume":"17","author":"Takagi","year":"2010","journal-title":"Endocr. Relat. Canc."},{"issue":"2","key":"10.1016\/j.mce.2018.10.019_bib96","doi-asserted-by":"crossref","first-page":"139","DOI":"10.7326\/0003-4819-98-2-139","article-title":"Evaluation of tamoxifen doses with and without fluoxymesterone in advanced breast cancer","volume":"98","author":"Tormey","year":"1983","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.mce.2018.10.019_bib97","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0006-291X(03)00694-6","article-title":"Production, purification, and functional analysis of recombinant human and mouse 17beta-hydroxysteroid dehydrogenase type 7","volume":"305","author":"Torn","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.mce.2018.10.019_bib98","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/ijc.23267","article-title":"Gene expression abnormalities in histologically normal breast epithelium of breast cancer patients","volume":"122","author":"Tripathi","year":"2008","journal-title":"Int. J. Canc."},{"issue":"6","key":"10.1016\/j.mce.2018.10.019_bib99","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/FPC.0b013e32832c484b","article-title":"Induction of 1C aldoketoreductases and other drug dose-dependent genes upon acquisition of anthracycline resistance","volume":"19","author":"Veitch","year":"2009","journal-title":"Pharmacogenetics Genom."},{"key":"10.1016\/j.mce.2018.10.019_bib100","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1476-4598-8-121","article-title":"Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers","volume":"8","author":"Velica","year":"2009","journal-title":"Mol. Canc."},{"issue":"2\u20135","key":"10.1016\/j.mce.2018.10.019_bib101","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jsbmb.2005.01.002","article-title":"Enzymes as modulators in malignant transformation","volume":"93","author":"Vihko","year":"2005","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"6","key":"10.1016\/j.mce.2018.10.019_bib102","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/bcp.12021","article-title":"Correlation of aldo-ketoreductase (AKR) 1C3 genetic variant with doxorubicin pharmacodynamics in Asian breast cancer patients","volume":"75","author":"Voon","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.mce.2018.10.019_bib103","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/jmcb\/mjv028","article-title":"Synergistic control of sex hormones by 17beta-HSD type 7: a novel target for estrogen-dependent breast cancer","volume":"7","author":"Wang","year":"2015","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.mce.2018.10.019_bib104","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jsbmb.2015.07.008","article-title":"Aromatase overexpression in dysfunctional adipose tissue links obesity to postmenopausal breast cancer","volume":"153","author":"Wang","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2018.10.019_bib105","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jsbmb.2017.06.009","article-title":"Inhibition of 17beta-hydroxysteroid dehydrogenase type 7 modulates breast cancer protein profile and enhances apoptosis by down-regulating GRP78","volume":"172","author":"Wang","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2018.10.019_bib106","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2407-3-9","article-title":"Activity and expression of progesterone metabolizing 5alpha-reductase, 20alpha-hydroxysteroid oxidoreductase and 3alpha(beta)-hydroxysteroid oxidoreductases in tumorigenic (MCF-7, MDA-MB-231, T-47D) and nontumorigenic (MCF-10A) human breast cancer cells","volume":"3","author":"Wiebe","year":"2003","journal-title":"BMC Canc."},{"issue":"2","key":"10.1016\/j.mce.2018.10.019_bib107","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.maturitas.2006.07.003","article-title":"Differential effects of progestogens, by type and regimen, on estrogen-metabolizing enzymes in human breast cancer cells","volume":"56","author":"Xu","year":"2007","journal-title":"Maturitas"},{"key":"10.1016\/j.mce.2018.10.019_bib108","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jsbmb.2017.04.009","article-title":"17beta-hydroxysteroid dehydrogenase type 5 is negatively correlated to apoptosis inhibitor GRP78 and tumor-secreted protein PGK1, and modulates breast cancer cell viability and proliferation","volume":"171","author":"Xu","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"12","key":"10.1016\/j.mce.2018.10.019_bib109","first-page":"2093","article-title":"Stromal PRs mediate induction of 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrial epithelium: a paracrine mechanism for inactivation of E2","volume":"15","author":"Yang","year":"2001","journal-title":"Mol. Endocrinol."},{"issue":"20","key":"10.1016\/j.mce.2018.10.019_bib110","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.1158\/1078-0432.CCR-13-1151","article-title":"Steroidogenic enzyme AKR1C3 is a novel androgen receptor-selective coactivator that promotes prostate cancer growth","volume":"19","author":"Yepuru","year":"2013","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.mce.2018.10.019_bib111","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.mce.2015.07.008","article-title":"11beta-Prostaglandin F2alpha, a bioactive metabolite catalyzed by AKR1C3, stimulates prostaglandin F receptor and induces slug expression in breast cancer","volume":"413","author":"Yoda","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1","key":"10.1016\/j.mce.2018.10.019_bib112","article-title":"The contribution of 17beta-hydroxysteroid dehydrogenase type 1 to the estradiol-estrone ratio in estrogen-sensitive breast cancer cells","volume":"7","author":"Zhang","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.mce.2018.10.019_bib113","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jsbmb.2014.09.017","article-title":"Reductive 17beta-hydroxysteroid dehydrogenases which synthesize estradiol and inactivate dihydrotestosterone constitute major and concerted players in ER+ breast cancer cells","volume":"150","author":"Zhang","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.mce.2018.10.019_bib114","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1080\/15548627.2016.1268302","article-title":"Acetylation targets HSD17B4 for degradation via the CMA pathway in response to estrone","volume":"13","author":"Zhang","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.mce.2018.10.019_bib115","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.biopha.2014.12.022","article-title":"Aldo-keto reductase 1C3 (AKR1C3) is associated with the doxorubicin resistance in human breast cancer via PTEN Loss","volume":"69","author":"Zhong","year":"2015","journal-title":"Biomed. Pharmacother."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720718303149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720718303149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:08:20Z","timestamp":1759586900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720718303149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":115,"alternative-id":["S0303720718303149"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2018.10.019","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of 17\u03b2HSDs in breast tissue and breast cancers","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2018.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}